The Horizons Tracker

JULY 31, 2024

Scholarly Publishers: Examining how to put data policies into operation through collaborative approaches, the report notes the current momentum in this direction. Industry: The report explores how Open Pharma is contributing to responsible data sharing in pharmaceutical research publications. ”

Pharmaceuticals 64

Pharmaceuticals Library Case Study Report 64

The Horizons Tracker

JUNE 9, 2021

The authors argue that it isn’t necessary for the public to understand how AI works in order for them to trust it, but they do need to know that someone with the knowledge to examine and understand how it’s operating has the authority to oversee it and sanction its developers if it begins to cause harm. ” Playing a part.

Document 87

Document Pharmaceuticals Discount Technology 87

Talent Anarchy 1

AUGUST 25, 2023

Pharmaceuticals: Medicines and healthcare products are also considered consumer non-durables. Product Development and Innovation For those who enjoy creativity and problem-solving, a career in product development and innovation within the consumer non-durables industry can be incredibly rewarding.

Career 60

Career Supply Chain Pharmaceuticals Industry 60

The Horizons Tracker

OCTOBER 9, 2019

One of the more interesting projects in this field is undertaken by pharmaceutical giant GSK, who offer their GSK Science in the Summer program to 2nd-6th graders to help engage them in STEM-related topics. The program operates from 27 locations across the United States, including New Mexico, Maine, Montana and Louisiana.

Pharmaceuticals 73

Pharmaceuticals Education ROI Project 73

Strategy Driven

DECEMBER 18, 2020

Gayhardt states that Hong Kong is already increasing its use of advanced fraud detection, biometric facial recognition, and other innovative AI technologies due to the pandemic. Clothing retailers, restaurants and grocery stores, and even some pharmaceutical products have all seen delays in 2020 as well.

Retail 77

Retail Supply Chain Pharmaceuticals Technology 77

Strategy Driven

JULY 13, 2011

Operating-cost productivity metrics might include the component costs for building an automobile or delivering a package, the rates of rework, and so forth. Pharmaceutical companies have long needed deep scientific-innovation leadership capabilities but relatively few general managers.

ROIC 62

ROIC Balanced Scorecard Metrics McKinsey 62

The Horizons Tracker

SEPTEMBER 10, 2021

By contrast, firms operating in areas such as online retail, pharmaceuticals, and information and communications technology, have all thrived. The researchers highlight the particular impact on businesses in the travel and hospitality sectors, who have all suffered due to the lockdown measures. Face-to-face interactions.

Pharmaceuticals 54

Pharmaceuticals Transportation Retail Long-term 54

The Horizons Tracker

FEBRUARY 22, 2022

billion and is estimated to be worth $48 billion by 2026, with the Covid pandemic driving growth, especially in the healthcare and pharmaceutical industries, but also in sectors such as automotive and defense. It’s a market that is already worth $3.1 “With 5G, you get fast upload speeds, up to 100Gbsp on many public networks.

Stephenson 109

Stephenson Wireless Christensen Automotive 109

Strategy Driven

NOVEMBER 29, 2016

Always at the forefront of innovation, technologies pioneered by the military are often adopted by the commercial sector; companies looking for cyber knowledge or network engineering skills can find this expertise among veterans. Bill Sebra is Chief Operations Executive at Korn Ferry Futurestep. About the Author.

Agility 50

Agility Pharmaceuticals Self-aware Learning-by-Doing 50

Strategy Driven

JANUARY 24, 2011

Closing the Execution Gap : How Great Leaders and Their Companies Get Results by Richard Lepsinger If an organization can’t execute its plans and initiatives, nothing else matters: not the most solid, well thought-out strategy, not the most innovative business model, not even technological breakthroughs that could transform an industry.

Execution 67

Execution Company 360-Degree Feedback Cooper 67

Strategy Driven

JUNE 22, 2018

When your operational and back office processes are aligned you work efficiently and productively. With life expectancy typically increasing and medical innovations positively impacting people’s health, for the first time since records began there are more seniors than children under 5 years. Your processes are A1.

Audience 50

Audience Niche Marketing How To Marketing Strategy 50

Harvard Business Review

FEBRUARY 22, 2011

Editor's note: This post is the first in a three-week series examining innovation in health care, published in partnership with the Advanced Leadership Initiative at Harvard University. Lack of consensus among players in a complex system is one of the biggest barriers to innovation. It's a classic change management problem.

Health Care 17

Health Care Innovation Pharmaceuticals Consensus 17

Harvard Business Review

JULY 8, 2016

China has not been a huge technology innovator, despite being the world’s second-largest investor in R&D , but Chinese businesses have found ways to use innovations in processes, business models, and customer experience to their disruptive advantage. This presents Western companies with a fresh challenge.

Business Model 14

Business Model Innovation Company Apparel 14

Harvard Business Review

SEPTEMBER 14, 2011

We recently visited the brand-new R&D lab of Dr Reddy's , one of India's leading pharmaceutical firms. Besides Dr Reddy's, several leading Indian firms are pioneering polycentric innovation: Tata Motors. Polycentric innovation won't work in organizations that promote groupthink. Cambridge, U.K. and the U.K.

Globalization 13

Globalization Innovation Decentralization Chemicals 13

Harvard Business Review

SEPTEMBER 20, 2011

A vast ideological gap on macro-economic policy divides Washington and much of the nation, but there is almost universal agreement on one solution: innovation. Innovation is now perceived as a panacea for job creation, income generation, economic growth, dollar strength, and the revival of the U.S. as global hegemon.

Innovation 15

Innovation Supply Chain Offshoring Policies 15

Harvard Business Review

SEPTEMBER 21, 2018

Corporate directors and executives alike recognize that today’s pace of change continues to accelerate and that firms need to innovate to stay ahead. But are boards doing enough to support innovation, as they should? We found that, overall, innovation does not rank as a top strategic challenge for the majority of boards.

Innovation 14

Innovation Short-term Telecommunications Long-term 14

Strategy Driven

MARCH 18, 2011

To demonstrate it, we’ve examined a number of industries and mapped the level of capabilities coherence in the portfolio of each of the major players against their operating margins over the past five years. Companies today operate in a business environment that encourages incoherence. We call this measure the ‘coherence premium.’

Resources 51

Resources Industry System Strategy 51

Harvard Business Review

FEBRUARY 17, 2011

Venture capitalists are increasingly interested in emerging markets, and in working with local funds based in those markets (despite the fact that reverse innovation in venture capital seems counterintuitive). In effect, the VCs at Nadathur Holdings serve as the executive team for a miniature healthcare innovation ecosystem.

Marketing 15

Marketing Venture Capitalist Biotechnology IPO 15

Harvard Business Review

MAY 16, 2011

True collaboration always has open-ended elements — ranging from precisely how new innovations will be implemented, to how products will fare in the market, and even to what priorities partners will pursue in the face of changes in the environment. Google uses a different approach to working with multiple external parties.

Software 19

Software Licensing Long-term Telecommunications 19

Harvard Business Review

AUGUST 3, 2016

That can benefit consumers through lower prices, more innovation, and better products. This is especially true in pharmaceutical markets where new and affordable drugs can improve and even save the lives of many people. Research has shown that pharma mergers reduce innovation. What’s the reason for this?

Innovation 8

Innovation Pharmaceuticals Company Price 8

Harvard Business Review

MAY 26, 2016

Operating margins for firms publicly listed in the US show a substantial and sustained rise. Firms engage in political “rent seeking”—lobbying for regulations that provide them sheltered markets—rather than competing on innovation. Profits are up. Corporate valuations are up as well.

Pharmaceuticals 14

Pharmaceuticals Politics Price Chemicals 14

Harvard Business Review

MAY 20, 2014

In pharmaceuticals, the largest company, Pfizer, is the result of decades of mergers. The current corporate entity is comprised of firms that used to be called: King Pharmaceuticals, Wyeth, American Cyanamid, Lederle, Pharmacia, Upjohn, Searle, SUGEN, Warner-Lambert, Parke-Davis and others.

Pharmaceuticals 15

Pharmaceuticals Banking Chemicals Entrepreneur 15

Harvard Business Review

MARCH 2, 2012

As global companies focus their strategies on developed and emerging markets, they require substantial cadres of leaders capable of operating effectively anywhere in the world. economy, expands America's global trade, and attracts foreign companies to base operations in the U.S.

Competitive Advantage 16

Competitive Advantage Globalization Development Intellectual Capital 16

Harvard Business Review

JUNE 27, 2012

Paul is an old friend who, until his recent retirement, worked as a senior scientist at a pharmaceutical company, where he managed a group of innovative researchers. Some good scientists left the company, and others lost their innovative spark. If this homogenization had worked, it might well have spelled disaster.

COO 15

COO Short-term Pharmaceuticals Innovation 15

Harvard Business Review

JANUARY 24, 2012

I'll be joined by five CEOs, among them George Halvorson , who heads the health care provider Kaiser Permanente, Vincent Forlenza who runs Becton Dickinson, the pharmaceutical company, and Tim Brown , the CEO of IDEO, the design and innovation firm.

Meyer 16

Meyer Goleman Emotional Intelligence Pharmaceuticals 16

Harvard Business Review

MARCH 11, 2013

Apple is probably the most successful and innovative company on earth over the past decade, and it's extremely closed and secretive. At the moment Apple can get away with this behavior, because it so powerful in the niche markets in which it operates and it has a small array of products. What's up with that?

Supply Chain 17

Supply Chain Open-book Software Niche Marketing 17

Harvard Business Review

FEBRUARY 6, 2018

Consider its decision to pursue the market for pharmaceutical distribution, or the recent announcement that it will be teaming up with Berkshire Hathaway and JP Morgan Chase to create joint solutions for reducing the health care spending of more than 1 million employees and their families.

Health Care 16

Health Care Retail Operations Insurance 16

Harvard Business Review

FEBRUARY 27, 2012

Michael Porter has done us all a service in identifying that the wealth of modern economies comes from the productivity, innovation and high wages found in their clustered industries — those industries that are found only in certain geographic areas and trade most of their output outside their home areas, both nationally and internationally.

Creativity 17

Creativity Porter Industry Pharmaceuticals 17

Harvard Business Review

OCTOBER 6, 2016

Right now, for example, the hot topic is “digital leadership” — driving organizations to be more innovative, iterative, and collaborative as they develop digital strategies to disrupt or transform their current business. The culture at GE, for example, centers on execution, simplicity, and innovation.

Leadership Pipeline 15

Leadership Pipeline Leadership After Action Review Pharmaceuticals 15

Harvard Business Review

JANUARY 8, 2013

Breaking down functional silos is key to everything from encouraging communication to building valuable connections to sparking innovation. arm of pharmaceuticals manufacturer Boehringer Ingelheim (BIPI). But, as we all know, bridging interdepartmental chasms is far easier said than done.

Company 13

Company Pharmaceuticals Health Care Participative 13

Harvard Business Review

APRIL 16, 2012

To enhance financial flexibility, companies have been retaining unprecedented amounts of cash on their balance sheets, calling it "strategic" cash to distinguish it from the "operating" cash that is needed to run the business. high technology or pharmaceutical) that are investing in projects with uncertain long-range payoffs.

Company 15

Company Cost of Capital Finance Long-term 15

Harvard Business Review

JANUARY 31, 2013

Second, we see a raft of innovations that will alter how products are designed, manufactured and sold — everything from nanotechnologies to 3D printing. Then, manufacturing's most important role is as a driver of innovation, trade, and productivity. Innovations Are Changing The Way We Design Products.

Globalization 13

Globalization Supply Chain Pharmaceuticals McKinsey 13

Harvard Business Review

SEPTEMBER 26, 2011

Some people may contend that given the high risks and many years it takes to develop a new drug, pharmaceutical companies are different animals from other firms. The fundamental challenges that CEOs of drug companies face are similar to those of any CEO: innovate, manage risk and uncertainty, and create long-term firm value.

CEO 18

CEO Short-term Long-term Pharmaceuticals 18

Harvard Business Review

NOVEMBER 1, 2017

We studied Omada’s program as part of our Harvard Medical School initiative to identify and share knowledge about innovative approaches to major health challenges that primary care providers play the lead in treating.

Health Care 20

Health Care Participative Wireless Pharmaceuticals 20

Harvard Business Review

JUNE 20, 2017

For organizations seeking to become more adaptive and innovative, culture change is often the most challenging part of the transformation. Innovation demands new behaviors from leaders and employees that are often antithetical to corporate cultures, which are historically focused on operational excellence and efficiency.

Company 15

Company Agility Innovation Learning-by-Doing 15

Harvard Business Review

OCTOBER 24, 2014

In addressing the billion-dollar adherence problem, Vitality (since acquired by NANTHEALTH ) considered the interests of the players in the diverse ecosystem, including pharmaceutical companies, retail pharmacies, and health care providers. Operations. My favorite example of this is iRobot , the maker of the innovative Roomba vacuum.

Productivity 11

Productivity Products Company Engineering 11

Harvard Business Review

DECEMBER 18, 2014

It used to be that hospitals and health systems operated as islands, selecting and purchasing medical supplies, devices and medications in isolation, and keeping their operational and leadership practices to themselves. While collaboration is always challenging, the health care benefits are by now clear.

Health Care 10

Health Care Retail Mayo Pharmaceuticals 10